Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Estomac / intestins » Néoplasie

07. Septembre 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

MII (maladie de Crohn/colite)

Troubles fonctionnels

Écriture:

Page 1 de 12231


	Articles 1 - 20 / 244616

	De-escalated total neoadjuvant therapy for the non-operative management of rectal cancer: Results of the NOM-3/TNT prospective cohort study. Clin Transl Radiat Oncol Skrzypiec B, Paciorek K, Pietrzak L, , Kaminski MF, Wro, Ho, Kapa, Ta, Olesi, Bujko K. PMID: 42703503 [PubMed]
	Trajectory identification of high-risk subgroups after colorectal cancer surgery in patients with minimal residual disease: a single-center longitudinal study. J Gastrointest Oncol Zhang Y, Liang L, Zhou R, Wu S, Zhou Y, Luo J, Zeng Y, Xu N, Wen Z. PMID: 42703488 [PubMed]
	Global, regional, and national burden of colorectal cancer attributable to modifiable risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. J Gastrointest Oncol Yu M, Lu YP. PMID: 42703476 [PubMed]
	Development of a postoperative risk scoring tool for elderly patients with early gastric cancer: an exploratory prognostic score derivation study. J Gastrointest Oncol Yoo J, Chung B, Kim J, Jeong SA, Min SH, Gong CS, Lee IS, Kim BS, Yoo MW, Yook JH, Kim S, Ko CS. PMID: 42703472 [PubMed]
	Prognostic impact of mucinous adenocarcinoma after curative surgery for stage I-III colorectal cancer: a large population-based cohort study. J Gastrointest Oncol Li J, Zeng T, Xie X, Li D, Yan K, Zhu H. PMID: 42703468 [PubMed]
	Second-line raltitrexed plus irinotecan (SALIRI) with bevacizumab, cetuximab, or alone for metastatic colorectal cancer: a prospective multicenter cohort-based secondary analysis of the SALLY trial. J Gastrointest Oncol Kou F, Wang X, Li J, Wang Z, Xu T. PMID: 42703466 [PubMed]
	Association of ctDNA RAS mutational status and clinical benefits in first-line metastatic colorectal cancer therapy with chemotherapy plus anti-EGFR (overall response rate and progression-free survival): a brief report of systematic review and meta-analysis. J Gastrointest Oncol Valladares-Ayerbes M, García Alfonso P, Heinemann V, Manca P, Stintzing S, Pietrantonio F, Montagut C, Safont Aguilera MJ, Maurel J, González Flores E, Vidal J, Formica V, Sabaté-Pina M, Alfonso-González V, Prat-Llorens G. PMID: 42703453 [PubMed]
	Assessing the Accuracy of the Association of Coloproctology of Great Britain and Ireland's Risk Assessment Tool for Polyp Cancer Management: A Retrospective Study. Cureus Akram F, Maryosh S, Kiwan O, Siddique K. PMID: 42703441 [PubMed]
	A study on screening of postoperative chemotherapy beneficial populations in stage II colorectal cancer based on diffusion weighted imaging and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography. J Gastrointest Oncol Wang X, Li L, Wang L, Chen W. PMID: 42703440 [PubMed]
	Real-world efficacy and safety of fruquintinib plus PD-1 inhibitors with or without radiotherapy in refractory metastatic colorectal cancer: a single-center retrospective cohort study. J Gastrointest Oncol Yi A, He L, Liu X, He Z, Liu J, Li B, Zhang H, Liu Y, Jiang C. PMID: 42703438 [PubMed]
	Development and preliminary validation of plasma cell-free DNA methylation-based diagnostic prediction model for colorectal cancer detection. J Gastrointest Oncol Qu Y, Huang R, Chen Y, Xia P, Huang B, Liu J, Wu L, Zhang R, Wang Q. PMID: 42703434 [PubMed]
	Impacts of neoadjuvant therapy on subsequent surgical difficulty, safety, and outcomes in locally advanced rectal cancer: a narrative review. J Gastrointest Oncol Tan Z, Cai J, Tang L, Liao J, Liu J, Guo Z, Zhang T, Lu JJ. PMID: 42703429 [PubMed]
	Clinical efficacy and safety of apatinib plus S-1 combined with oxaliplatin (SOX) in postoperative stage III gastric cancer patients with high VEGFR-2 expression. J Gastrointest Oncol Deng Q, Wang R, Qi H, Zhou Y, Chen J, Zhang L, Gao X, Jin X, Yan Z, Wang H, Wang Q, Yang H. PMID: 42703403 [PubMed]
	Histopathological subtypes independently predict survival in ampullary carcinoma: a contemporary SEER nomogram study. J Gastrointest Oncol Zhang M, Tong K, Jing C, Wu H, Du X, Liu K. PMID: 42703401 [PubMed]
	Prediction-model development and temporal validation for six-month cancer-specific mortality in de novo metastatic gastroesophageal junction adenocarcinoma: a SEER-based study. J Gastrointest Oncol Xia L, Wang Z, Guo X, Men X, Fan W, Lu Q. PMID: 42703337 [PubMed]
	Chronic psychological stress and gastric cancer: bidirectional associations, biological mechanisms, and clinical implications-a narrative review. J Gastrointest Oncol Zhao L, Yang L, Zhao N, Ding Q, Lu P, Feng X, Liu M. PMID: 42703314 [PubMed]
	Radiomic prediction of early progression at 2 years post-treatment in patients with resectable rectal cancer based on rectal tumor and mesentery characteristics: a two-center study. J Gastrointest Oncol Quan T, Wu L, Chen S, Liu Y, Lu L, Zhu J. PMID: 42703292 [PubMed]
	An Insight into the Emerging Role of Extracellular Vesicle-derived Noncoding RNAs in Colorectal Cancer. Microrna Jayaraman V, Apthi S, Datta L, Palaniyandi K, Gnanasampanthapandian D. PMID: 42703176 [PubMed - indexed for MEDLINE]
	Profiling neoadjuvant therapy response in rectal cancer using meta-analysis of publicly available transcriptomic RNA-seq datasets. Mol Oncol Stanojevic A, Stroggilos R, Marinkovic M, Djuric A, Stojanovic-Rundic S, Jankovic R, Castellvi-Bel S, Fijneman RJA, Vlahou A, Zoidakis J, Cavic M. PMID: 42703166 [PubMed - as supplied by publisher]
	Awareness, Attitudes, and Expectations of Indian Cancer Patients and Their Caregivers on Hereditary Cancers and Genetic Testing at a Tertiary Cancer Centre in India. J Genet Couns Pathak RS, Angre A, Talker J, Sarin R. PMID: 42702960 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 244616

Page 1 de 12231



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité